Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Ocular Therapeutix (OCUL) Equity Ratio: 2013-2025

Historic Equity Ratio for Ocular Therapeutix (OCUL) over the last 12 years, with Sep 2025 value amounting to 0.63.

  • Ocular Therapeutix's Equity Ratio fell 12.45% to 0.63 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.63, marking a year-over-year decrease of 12.45%. This contributed to the annual value of 0.69 for FY2024, which is 90.47% up from last year.
  • According to the latest figures from Q3 2025, Ocular Therapeutix's Equity Ratio is 0.63, which was down 7.28% from 0.68 recorded in Q2 2025.
  • Ocular Therapeutix's Equity Ratio's 5-year high stood at 0.76 during Q1 2024, with a 5-year trough of 0.03 in Q2 2023.
  • Over the past 3 years, Ocular Therapeutix's median Equity Ratio value was 0.66 (recorded in 2025), while the average stood at 0.49.
  • As far as peak fluctuations go, Ocular Therapeutix's Equity Ratio plummeted by 93.38% in 2023, and later soared by 2,799.88% in 2024.
  • Over the past 5 years, Ocular Therapeutix's Equity Ratio (Quarterly) stood at 0.43 in 2021, then crashed by 44.82% to 0.24 in 2022, then skyrocketed by 52.56% to 0.36 in 2023, then surged by 90.47% to 0.69 in 2024, then dropped by 12.45% to 0.63 in 2025.
  • Its Equity Ratio was 0.63 in Q3 2025, compared to 0.68 in Q2 2025 and 0.66 in Q1 2025.